Trends and disparities in lung cancer mortality among older adults with chronic lower respiratory diseases: A nationwide analysis of US data from 1999 to 2020.

e22547 Background: Lung cancer is a leading cause of mortality among older adults with a history of chronic lower respiratory diseases (CLRD). Examining trends and disparities in lung cancer mortality within this population is crucial for informing interventions aimed at improving survival outcomes and quality of life for these patients. Methods: We analyzed data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database (1999–2020) to assess lung cancer mortality in adults ≥65 with CLRD. Identified UCD ICD-10 codes for lung cancer were: C33, C34, C39.9, C78.0, C78.3, D02.1-D02.4, D14.2-D14.4. ICD-10 codes for CLRD (J40-47) were added as contributing cause. Age-Adjusted Mortality Rates (AAMRs) were calculated per 100,000 and stratified for age, sex, race, and region. Joinpoint Regression (Version 5.1.0, National Cancer Institute) assessed the temporal trends as annual percentage changes (APCs). Results: Nationwide analysis between 1999-2020 shows the AAMRs had a general decline, starting with 50.4 in 1999 and ending with 38.5 in 2020, with a mean APC of -1.44. Males had a higher mean AAMR (58.7) than females (35.6), but saw a greater fall in mortality rates (APC male: -2.25, APC female: -0.75). White individuals had the greatest mean AAMR (50.2). Geographically, Midwestern US had the highest mean AAMR (52.5). Urban-rural AAMR differences were noted as well (Urban: 42.3, Rural: 54.9). Conclusions: Our study reveals a declining trend in lung cancer mortality among elderly CLRD patients, though gender and ethnic disparities persist. Rural areas, particularly in the Midwest, remain at higher risk, highlighting the need for targeted healthcare interventions to improve outcomes. Lung cancer mortality trends in U.S. older adults with CLRD, 1999–2020. Variable AAMR(95% CI) APC(95% CI) Overall 45.2 (45, 45.3) 1999-2007: -0.20* (-0.72, 0.54) 2007-2020: -2.05* (-2.34, -1.83) Women 35.6 (35.4, 35.7) 1999-2007: 1.12* (0.64, 1.76) 2007-2020: -1.59* (-1.84, -1.36) Men 58.7 (58.4, 58.9) 1999-2006: -1.36 (-2.00, 0.48) 2006-2020: -2.59* (-3.13, -2.37) White 50.2 (50, 50.3) 1999-2006: 0.39 (-0.08, 1.04) 2006-2020: -1.70* (-1.89, -1.53) Black/African American 35 (34.6, 35.5) 1999-2020: -1.32* (-1.58, -1.04) American Indian/Alaska Native 44.1 (42.2, 46.1) 1999-2004: 7.62* (0.84, 35.56) 2004-2020: -1.12* (-4.37, -0.11) Hispanic/Latino 15.5 (15.2, 15.8) 1999-2020: -2.31* (-2.63, -1.95) Asian/Pacific Islander 13.9 (13.5, 14.3) 1999-2007: -1.12* (-4.37, -0.11) 2007-2020: -4.22* (-5.67, -3.45) Rural 58.3 (57.9, 58.6) 1999-2004: 2.01* (0.96, 3.72) 2004-2020: -0.98* ( -1.18, -0.80) Urban 42.3 (42.1, 42.4) 1999-2007: -0.51 (-1.06, 0.43) 2007-2020: -2.25* (-2.65, -1.97)

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.e22547
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends and disparities in lung cancer mortality among older adults with chronic lower respiratory diseases: A nationwide analysis of US data from 1999 to 2020.

Fizza Mohsin, Ahmad Shahid, Hamza Imran, Asim Jamal Shaikh et al.
Journal of Clinical Oncology
Global Cancer Incidence and Screening
article

Trends and disparities in lung cancer mortality among older adults with chronic lower respiratory diseases: A nationwide analysis of US data from 1999 to 2020.

Fizza Mohsin, Ahmad Shahid, Hamza Imran, Asim Jamal Shaikh, Abdullah Naveed, Utsav Joshi, Komail Khalid Meer, Fahira Rasheed, Ayesha Mubbashir, Fatima Tuz Zahra, Fakhar Latif, Fatimah Hoda, Muhammad Saim Siddiqui, Z.A. Shaikh, AF Butt, Yasmeen Ali, Umar Ali Khan, Aaima Memon, Uzair Ahmed, Taimur Faheem
article en

Abstract

e22547 Background: Lung cancer is a leading cause of mortality among older adults with a history of chronic lower respiratory diseases (CLRD). Examining trends and disparities in lung cancer mortality within this population is crucial for informing interventions aimed at improving survival outcomes and quality of life for these patients. Methods: We analyzed data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database (1999–2020) to assess lung cancer mortality in adults ≥65 with CLRD. Identified UCD ICD-10 codes for lung cancer were: C33, C34, C39.9, C78.0, C78.3, D02.1-D02.4, D14.2-D14.4. ICD-10 codes for CLRD (J40-47) were added as contributing cause. Age-Adjusted Mortality Rates (AAMRs) were calculated per 100,000 and stratified for age, sex, race, and region. Joinpoint Regression (Version 5.1.0, National Cancer Institute) assessed the temporal trends as annual percentage changes (APCs). Results: Nationwide analysis between 1999-2020 shows the AAMRs had a general decline, starting with 50.4 in 1999 and ending with 38.5 in 2020, with a mean APC of -1.44. Males had a higher mean AAMR (58.7) than females (35.6), but saw a greater fall in mortality rates (APC male: -2.25, APC female: -0.75). White individuals had the greatest mean AAMR (50.2). Geographically, Midwestern US had the highest mean AAMR (52.5). Urban-rural AAMR differences were noted as well (Urban: 42.3, Rural: 54.9). Conclusions: Our study reveals a declining trend in lung cancer mortality among elderly CLRD patients, though gender and ethnic disparities persist. Rural areas, particularly in the Midwest, remain at higher risk, highlighting the need for targeted healthcare interventions to improve outcomes. Lung cancer mortality trends in U.S. older adults with CLRD, 1999–2020. Variable AAMR(95% CI) APC(95% CI) Overall 45.2 (45, 45.3) 1999-2007: -0.20* (-0.72, 0.54) 2007-2020: -2.05* (-2.34, -1.83) Women 35.6 (35.4, 35.7) 1999-2007: 1.12* (0.64, 1.76) 2007-2020: -1.59* (-1.84, -1.36) Men 58.7 (58.4, 58.9) 1999-2006: -1.36 (-2.00, 0.48) 2006-2020: -2.59* (-3.13, -2.37) White 50.2 (50, 50.3) 1999-2006: 0.39 (-0.08, 1.04) 2006-2020: -1.70* (-1.89, -1.53) Black/African American 35 (34.6, 35.5) 1999-2020: -1.32* (-1.58, -1.04) American Indian/Alaska Native 44.1 (42.2, 46.1) 1999-2004: 7.62* (0.84, 35.56) 2004-2020: -1.12* (-4.37, -0.11) Hispanic/Latino 15.5 (15.2, 15.8) 1999-2020: -2.31* (-2.63, -1.95) Asian/Pacific Islander 13.9 (13.5, 14.3) 1999-2007: -1.12* (-4.37, -0.11) 2007-2020: -4.22* (-5.67, -3.45) Rural 58.3 (57.9, 58.6) 1999-2004: 2.01* (0.96, 3.72) 2004-2020: -0.98* ( -1.18, -0.80) Urban 42.3 (42.1, 42.4) 1999-2007: -0.51 (-1.06, 0.43) 2007-2020: -2.25* (-2.65, -1.97)

Journal of Clinical OncologyVol. 43(16_suppl)
Maimonides Medical Center (US), Institute of Business Administration Karachi (PK), University of South Florida (US), Moffitt Cancer Center (US), Dow University of Health Sciences (PK), Bahria University (PK)
Openalex Percentile: Top 81%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.